SIDANIS is focused on preclinical and early clinical phases of drug development, spanning the pharmaceutical value chain from drug discovery to proof of efficacy and safety in clinical trials. Later steps will be carried out with co-operation partners. The company was founded in Hamburg, Germany, and is privately owned. Until now, SIDANIS led its business without direct employees and laboratories and pursued its objectives through contract awards. After having achieved major development milestones recently, the operative business is planned to begin in 2021 when financing is secured. Management
View Top Employees from Sidanis Pharma GmbHWebsite | http://sidanis.com |
Revenue | $9 million |
Employees | 1 (1 on RocketReach) |
Address | 64 Grandweg, Hamburg, Hamburg 22529, DE |
Phone | +49 40 76999249 |
Fax | +49 32 121228264 |
Technologies |
HTML,
Apache,
Apache HTTP Server
+2 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Sidanis Pharma GmbH employee's phone or email?
The Sidanis Pharma GmbH annual revenue was $9 million in 2023.
1 people are employed at Sidanis Pharma GmbH.
Sidanis Pharma GmbH is based in Hamburg, Hamburg.
The NAICS codes for Sidanis Pharma GmbH are [3254, 32541, 32, 325].
The SIC codes for Sidanis Pharma GmbH are [28, 283].